Betoptic S 0.25 % Ophthalmic Suspension
- RxCUI
- 213729
- RxNorm name
- Betoptic S 0.25 % Ophthalmic Suspension
- Display name
- Betoptic S 0.25 % Ophthalmic Suspension
- Full name
- Betoptic S 0.25 % Ophthalmic Suspension
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:08
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Betoptic S | BETAXOLOL HYDROCHLORIDE | Novartis Pharmaceuticals Corporation | 905ba189-456c-4aa4-8231-39a971374ad8 | 2025-01-22 | Warnings, Adverse reactions | 213729 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 905ba189-456c-4aa4-8231-39a971374ad8 | Betoptic S 0.25 % Ophthalmic Suspension | PSN | 4 | These highlights do not include all the information needed to use BETOPTIC S safely and effectively. See full prescribing information for BETOPTIC S. BETOPTIC S ® (betaxolol hydrochloride ophthalmic suspension), 0.25% as base, for topical ophthalmic use Initial U.S. Approval: 1985 | 20250122 |
| 905ba189-456c-4aa4-8231-39a971374ad8 | Betoptic S 0.25 % Ophthalmic Suspension | SY | 4 | These highlights do not include all the information needed to use BETOPTIC S safely and effectively. See full prescribing information for BETOPTIC S. BETOPTIC S ® (betaxolol hydrochloride ophthalmic suspension), 0.25% as base, for topical ophthalmic use Initial U.S. Approval: 1985 | 20250122 |
| 905ba189-456c-4aa4-8231-39a971374ad8 | betaxolol 2.5 MG/ML Ophthalmic Suspension [Betoptic S] | SBD | 4 | These highlights do not include all the information needed to use BETOPTIC S safely and effectively. See full prescribing information for BETOPTIC S. BETOPTIC S ® (betaxolol hydrochloride ophthalmic suspension), 0.25% as base, for topical ophthalmic use Initial U.S. Approval: 1985 | 20250122 |
| 905ba189-456c-4aa4-8231-39a971374ad8 | Betoptic S 2.5 MG/ML (betaxolol hydrochloride 2.8 MG/ML) Ophthalmic Suspension | SY | 4 | These highlights do not include all the information needed to use BETOPTIC S safely and effectively. See full prescribing information for BETOPTIC S. BETOPTIC S ® (betaxolol hydrochloride ophthalmic suspension), 0.25% as base, for topical ophthalmic use Initial U.S. Approval: 1985 | 20250122 |